Companies: 10,795·Total market cap: $144.5T
BetterLife Pharma Inc.

BetterLife Pharma Inc.

BETRFOTCHealthcare● Active
$0.04
+$0.00(+5.16%)
Market Cap$7248058
P/E Ratio—
52W High$0.078
52W Low$0.028
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

BetterLife Pharma Inc. (BETRF) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001464165 · BETRF · OTC · as of Jun 9, 2026

Filing snapshot

236
Total Filings
20-F
Latest Form
2026-06-01
Most Recent
2010
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001464165 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-06-01
Fiscal Year End
Jun 1, 2026
Accession No.
0001477932-26-003553
Primary Document
betrf_20f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001464165 · Accession 0001477932-26-003553

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-04-13
View 6-K on SEC
8-KCurrent Report
FORM 8-K
2019-05-21Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
20-FAnnual Report (Foreign Issuer)
FORM 20-F
2026-06-01
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-13
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-09-29
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-07-28
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-06-27
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-06-23
View
20-FAnnual Report (Foreign Issuer)
FORM 20-F
2025-06-02
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-05-30
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-05-07
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-04-07
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-12-31
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-12-09
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-10-15
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-09-26
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-08-29
View
Showing 1–15 of 236 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001464165  |  Exchange: OTC · Healthcare

BetterLife Pharma Inc. (OTC: BETRF) has submitted 236 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2010. As a Healthcare sector company with CIK 0001464165, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is BetterLife Pharma Inc.'s most comprehensive regulatory disclosure. The most recent BetterLife Pharma Inc. 10-K was filed on 2026-06-01 for fiscal year ending 2026. Historical BETRF 10-K annual reports are available from 2009 through 2026.

Investors researching BetterLife Pharma Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
TXTM SEC Filings →CUBT SEC Filings →QNNTF SEC Filings →GLWLF SEC Filings →CPMV SEC Filings →CHMMF SEC Filings →PHRRF SEC Filings →BIXT SEC Filings →
→ BETRF Financials→ BETRF Earnings→ BETRF Insider Trades

Frequently Asked Questions

BETRF SEC Filings · 8 questions

BetterLife Pharma Inc. (BETRF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 236 filings and access original documents at no cost. BetterLife Pharma Inc.'s CIK is 0001464165.

BETRF SEC filingsBetterLife Pharma Inc. SEC documentsfind BETRF 10-K